proxyvotesnow.com

Home › Companies › CORE LABORATORIES INC. › 2023-2024

CORE LABORATORIES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORE LABORATORIES INC.’s Form 8-K, filed 2024-05-10 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 5Ballot items
  • 263Asset managers
  • 1,471Fund votes
  • 2024-05-08Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CORE LABORATORIES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CORE LABORATORIES INC.

These tallies are CORE LABORATORIES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORE LABORATORIES INC. — official shareholder meeting results, meeting held 2024-05-08
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lawrence Bruno 37,354,023---- 962,5282,919,136 Majority: yes
Elect Director: Kwaku Temeng 33,030,809---- 5,285,7422,919,136 Majority: yes
Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2024 was approved as follows: 40,402,356802,76330,568 ---- Passed
Proposal 3: Approving the Compensation of the Company's Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows: 36,411,6841,822,49782,370 --2,919,136 Passed
Proposal 4: Approving the Amendment of the Company's Long-Term Incentive Plan : The amendment and restatement of the Company's 2020 Long-Term Incentive Plan, the principal purposes of which are to (i) increase the number of shares authorized thereunder and (ii 36,742,2681,468,975105,308 --2,919,136 Passed

Source: CORE LABORATORIES INC., Form 8-K, filed with the SEC on 2024-05-10 — read the filing on EDGAR.

How asset managers voted at the CORE LABORATORIES INC. 2023-2024 meeting

Each item below shows how the 263 asset managers that disclosed a CORE LABORATORIES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables;

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 19 wordings of this item as funds reported it.

95% Passed · of votes cast

FOR 95%
FOR: 36,411,684AGAINST: 1,822,497

CORE LABORATORIES INC.’s own tally for this item (“Proposal 3: Approving the Compensation of the Company's Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows:”): 36,411,684 for, 1,822,497 against — passed, per its Form 8-K filed 2024-05-10 (Item 5.07). Of all 46,899,863 outstanding shares: 78% for, 4% against (82% of the company cast a for/against vote).

The 261 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 97%
FOR: 96.7%AGAINST: 3.2%ABSTAIN: 0.0%UNKNOWN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the sectio” at CORE LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Curi RMB Capital, LLC12,000,0000 00For
Vanguard5,635,1480 00For
ARIEL INVESTMENT TRUST5,255,9900 00For
BlackRock4,646,084162,723 00For
ARIEL INVESTMENTS, LLC3,190,9140 00For
State Street2,655,576630 00For
EARNEST PARTNERS LLC2,146,2625,803 00For
CONGRESS ASSET MANAGEMENT CO /MA1,459,1770 00For
Charles Schwab1,185,5530 00For
HARBOR FUNDS1,143,9580 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,060,0000 00For
Royce1,033,0660 00For
Fidelity643,9200 00For
DISCIPLINED GROWTH INVESTORS INC /MN611,5200 00For
GEODE CAPITAL MANAGEMENT, LLC554,9330 00For
WEATHERBIE CAPITAL, LLC0552,508 00Against
VAN ECK ASSOCIATES CORP547,1990 00For
VanEck ETF Trust547,1990 00For
BOSTON TRUST WALDEN FUNDS503,2020 00For
Dimensional430,0440 00For
Northern Trust409,35830 00For
Fisher Asset Management, LLC82,654252,025 00Against
Columbia Threadneedle317,2910 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC292,1800 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC285,1040 00For

Showing the 25 largest of 261 asset managers. See all 261 in the interactive database.

2. To re-elect two current Class III Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2027 and until their successors shall have been duly elected and qualified: Kwaku Temeng

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%14%
FOR: 33,030,809WITHHELD: 5,285,742

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Kwaku Temeng”): 33,030,809 for, 5,285,742 withheld, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,899,863 outstanding shares: 70% for, 11% withheld (82% of the company cast a for/withheld vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (21,469,928 for, 0 against).

FOR 92%8%
FOR: 21,469,928 (91.9%)ABSTAIN: 1,896,061 (8.1%)
Largest asset managers voting on “To re-elect two current Class III Directors to serve under the terms and conditions described within the proxy” at CORE LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,543,1780 00For
ARIEL INVESTMENT TRUST5,255,9900 00For
BlackRock3,180,7560 00For
HARBOR FUNDS1,143,9580 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,060,0000 00For
Royce1,026,1500 00For
State Street2,1030 928,2460Abstain
Fidelity592,3430 00For
Charles Schwab585,6640 00For
VanEck ETF Trust00 547,1990Abstain
BOSTON TRUST WALDEN FUNDS503,2020 00For
Dimensional319,5190 00For
Columbia Threadneedle317,2910 00For
ALGER FUNDS00 241,5680Abstain
Empower178,3640 31,2930For
TIAA133,5150 00For
Principal128,1980 00For
Equitable74,0680 48,3000For
CARILLON SERIES TRUST122,2430 00For
Jackson National118,1580 00For
KINETICS MUTUAL FUNDS INC111,6000 00For
KINETICS PORTFOLIOS TRUST111,6000 00For
HOTCHKIS & WILEY FUNDS /DE/98,4000 00For
WisdomTree94,3390 00For
QUANTITATIVE MASTER SERIES LLC82,8140 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

3. To re-elect two current Class III Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2027 and until their successors shall have been duly elected and qualified: Lawrence Bruno

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 37,354,023WITHHELD: 962,528

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Lawrence Bruno”): 37,354,023 for, 962,528 withheld, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,899,863 outstanding shares: 80% for, 2% withheld (82% of the company cast a for/withheld vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (23,322,326 for, 0 against).

FOR 99.8%
FOR: 23,322,326 (99.8%)ABSTAIN: 43,663 (0.2%)
Largest asset managers voting on “To re-elect two current Class III Directors to serve under the terms and conditions described within the proxy” at CORE LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,543,1780 00For
ARIEL INVESTMENT TRUST5,255,9900 00For
BlackRock3,180,7560 00For
HARBOR FUNDS1,143,9580 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,060,0000 00For
Royce1,026,1500 00For
State Street930,0690 2800For
Fidelity592,3430 00For
Charles Schwab585,6640 00For
VanEck ETF Trust547,1990 00For
BOSTON TRUST WALDEN FUNDS503,2020 00For
Dimensional319,5190 00For
Columbia Threadneedle317,2910 00For
ALGER FUNDS241,5680 00For
Empower178,3640 31,2930For
TIAA133,5150 00For
Principal128,1980 00For
Equitable122,3680 00For
CARILLON SERIES TRUST122,2430 00For
Jackson National118,1580 00For
KINETICS MUTUAL FUNDS INC111,6000 00For
KINETICS PORTFOLIOS TRUST111,6000 00For
HOTCHKIS & WILEY FUNDS /DE/98,4000 00For
WisdomTree94,3390 00For
QUANTITATIVE MASTER SERIES LLC82,8140 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

4. TO APPROVE AND RESOLVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2020 LONG-TERM INCENTIVE PLAN, THE PRINCIPAL PURPOSES OF WHICH ARE TO (I) INCREASE THE NUMBER OF SHARES AUTHORIZED THEREUNDER AND (II) EXTEND THE TERM OF SUCH PLAN THROUGH MAY 8, 2034.

COMPENSATIONCompany result: Passed

Combines 4 wordings of this item as funds reported it.

96% Passed · of votes cast

FOR 96%
FOR: 36,742,268AGAINST: 1,468,975

CORE LABORATORIES INC.’s own tally for this item (“Proposal 4: Approving the Amendment of the Company's Long-Term Incentive Plan : The amendment and restatement of the Company's 2020 Long-Term Incentive Plan, the principal purposes of which are to (i) increase the number”): 36,742,268 for, 1,468,975 against — passed, per its Form 8-K filed 2024-05-10 (Item 5.07). Of all 46,899,863 outstanding shares: 78% for, 3% against (81% of the company cast a for/against vote).

The 73 asset managers below cast 99.6% of the shares they voted on this item FOR (23,254,562 for, 72,844 against).

FOR 99.6%
FOR: 23,254,562 (99.7%)AGAINST: 72,844 (0.3%)ABSTAIN: 7,290 (0.0%)
Largest asset managers voting on “TO APPROVE AND RESOLVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2020 LONG-TERM INCENTIVE PLAN, THE PRINC” at CORE LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,543,1780 00For
ARIEL INVESTMENT TRUST5,255,9900 00For
BlackRock3,180,7560 00For
HARBOR FUNDS1,143,9580 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,060,0000 00For
Royce1,026,1500 00For
State Street930,189160 00For
Fidelity592,3430 00For
Charles Schwab585,6640 00For
VanEck ETF Trust547,1990 00For
BOSTON TRUST WALDEN FUNDS503,2020 00For
Dimensional319,5190 00For
Columbia Threadneedle317,2910 00For
ALGER FUNDS241,5680 00For
Empower178,3640 00For
TIAA133,5150 00For
Principal128,1980 00For
Equitable122,3680 00For
CARILLON SERIES TRUST122,2430 00For
Jackson National118,1580 00For
KINETICS MUTUAL FUNDS INC111,6000 00For
KINETICS PORTFOLIOS TRUST111,6000 00For
HOTCHKIS & WILEY FUNDS /DE/98,4000 00For
WisdomTree94,3390 00For
QUANTITATIVE MASTER SERIES LLC82,8140 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

5. To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ending December 31, 2024;

AUDIT-RELATEDCompany result: Passed

Combines 5 wordings of this item as funds reported it.

98% Passed · of votes cast

FOR 98%
FOR: 40,402,356AGAINST: 802,763

CORE LABORATORIES INC.’s own tally for this item (“Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, ”): 40,402,356 for, 802,763 against — passed, per its Form 8-K filed 2024-05-10 (Item 5.07). Of all 46,899,863 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (23,299,833 for, 27,573 against).

FOR 99.8%
FOR: 23,299,833 (99.9%)AGAINST: 27,573 (0.1%)ABSTAIN: 7,290 (0.0%)
Largest asset managers voting on “To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ” at CORE LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,543,1780 00For
ARIEL INVESTMENT TRUST5,255,9900 00For
BlackRock3,180,7560 00For
HARBOR FUNDS1,143,9580 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,060,0000 00For
Royce1,026,1500 00For
State Street930,189160 00For
Fidelity592,3430 00For
Charles Schwab585,6640 00For
VanEck ETF Trust547,1990 00For
BOSTON TRUST WALDEN FUNDS503,2020 00For
Dimensional319,5190 00For
Columbia Threadneedle317,2910 00For
ALGER FUNDS241,5680 00For
Empower178,3640 00For
TIAA133,5150 00For
Principal128,1980 00For
Equitable122,3680 00For
CARILLON SERIES TRUST122,2430 00For
Jackson National118,1580 00For
KINETICS MUTUAL FUNDS INC111,6000 00For
KINETICS PORTFOLIOS TRUST111,6000 00For
HOTCHKIS & WILEY FUNDS /DE/98,4000 00For
WisdomTree94,3390 00For
QUANTITATIVE MASTER SERIES LLC82,8140 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

Largest CORE LABORATORIES INC. shareholders voting in 2023-2024

Ranked by the number of CORE LABORATORIES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 46,899,863 shares outstanding at the time of that meeting.

Top CORE LABORATORIES INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Curi RMB Capital, LLC 25.59%
2Vanguard 12.02%
3ARIEL INVESTMENT TRUST 11.21%
4BlackRock 10.25%
5ARIEL INVESTMENTS, LLC 6.80%
6State Street 5.66%
7EARNEST PARTNERS LLC 4.59%
8CONGRESS ASSET MANAGEMENT CO /MA 3.11%
9Charles Schwab 2.53%
10HARBOR FUNDS 2.44%

Reported CORE LABORATORIES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CORE LABORATORIES INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 15.48% 13F
Vanguard Group 6.50% 13F
State Street 4.47% 13F
Geode Capital 2.09% 13F
Dimensional Fund Advisors 1.72% 13F
Charles Schwab 1.33% 13F
Citadel Advisors 1.13% 13F
Northern Trust 1.08% 13F
Morgan Stanley 1.08% 13F
BNY Mellon 1.02% 13F

Percentages above are of 46,899,863 shares outstanding, as reported by CORE LABORATORIES INC. on its Form 10-Q dated 2024-04-19 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORE LABORATORIES INC.’s 10-Q dated 2024-04-19. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At CORE LABORATORIES INC.'s shareholder meeting held 2024-05-08, in the 2023-2024 proxy season, 263 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,471 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation philosophy, policies and procedures… — the proposal passed with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CORE LABORATORIES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-10.

CORE LABORATORIES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.